Glaukos

Glaukos Current Liabilities

The Current Liabilities of Glaukos (GKOS) as of Oct 28, 2026 is 101.27 M USD. In the previous year, Current Liabilities was 139.70 M USD — a change of -27.50% (lower).

Current Liabilities

101.27 MUSD

YoY

-27.50%

Last updated:

Current Liabilities of Glaukos is 2025 101.27 M USD. Current Liabilities of Glaukos was 2024 139.70 M USD. It decreases by -27.50% lower compared to the previous year.

The Glaukos Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2018
54.37 M USD
Jan 1, 2019
111.16 M USD
Jan 1, 2020
95.00 M USD
Jan 1, 2021
119.36 M USD
Jan 1, 2022
130.36 M USD
Jan 1, 2023
136.82 M USD
Jan 1, 2024
139.70 M USD
Jan 1, 2025
101.27 M USD
The Glaukos Current Liabilities history
YEARCurrent LiabilitiesYoY
101.27 MUSD-27.50%
139.70 MUSD+2.10%
136.82 MUSD+4.96%
130.36 MUSD+9.21%
119.36 MUSD+25.64%
95.00 MUSD-14.54%
111.16 MUSD+104.47%
54.37 MUSD+15.21%
47.19 MUSD+53.02%
30.84 MUSD-16.79%
37.06 MUSD+5.33%
35.19 MUSD+364.70%
7.57 MUSD-51.52%
15.62 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Glaukos Stock analysis

What does Glaukos do? Glaukos Corp is a medical technology company specializing in developing devices and therapies for treating eye diseases. It was founded in 1998 by employees of the ophthalmology center at the University of California San Francisco. The company focuses on utilizing new technologies and therapies to improve the vision quality of patients. They have developed innovative products for diagnosing and treating various eye conditions, including glaucoma. Their core business involves manufacturing and distributing medical devices for glaucoma treatment, such as the iStent implant. They have also partnered with other institutions to advance research and development in the field of ophthalmology. In 2018, Glaukos Corp acquired the German manufacturer Markt II Medical, expanding their product offerings for a wider range of eye diseases. In summary, Glaukos Corp is an innovative medical technology company that aims to enhance patients' vision quality while minimizing the risks of eye surgery. Glaukos is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Glaukos stock

Current Liabilities of Glaukos is 101.27 M USD in 2025.

Current Liabilities of Glaukos changed from 139.70 M USD to 101.27 M USD, representing a -27.50% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities Glaukos since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Glaukos historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Glaukos

All Key Metrics — Glaukos